XML 94 R81.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements (Narrative) (Details)
3 Months Ended 12 Months Ended
May 19, 2021
USD ($)
milestone
Feb. 17, 2021
USD ($)
Jan. 04, 2021
USD ($)
milestone
Jun. 30, 2020
USD ($)
Mar. 02, 2020
USD ($)
Oct. 31, 2019
USD ($)
Mar. 31, 2022
USD ($)
shares
Dec. 31, 2021
USD ($)
Dec. 31, 2020
shares
Jun. 30, 2020
USD ($)
Mar. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Mar. 31, 2020
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis                          
Fair value of contingent consideration upon acquisition $ 10,000,000                   $ 9,973,000 $ 6,430,000  
Payment of contingent consideration for business acquisition               $ 900,000     880,000 0 $ 0
Change in fair value of contingent consideration                     (3,509,000) 5,716,000  
Treasury shares reissued (in shares) | shares             4,010   390,397        
Impairment of equity method investments                     0 0 0
Equity securities without readily determinable fair value impairment                     0 2,011,000 0
Initial cost basis of securities                       2,000,000  
Impairment of intangible assets                     7,000,000 0 0
Discontinued Operations                          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis                          
Impairment of intangible assets                     7,000,000    
Lifesize, Inc.                          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis                          
Equity method investment         $ 5,500,000                
Proceeds from sale of equity method investments         $ 45,300,000                
Marlin                          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis                          
Equity method investment             $ 21,400,000       21,400,000 26,700,000  
Fair Value, Measurements, Recurring                          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis                          
Equity method investment             40,200,000       40,200,000 40,700,000  
Fair Value, Measurements, Recurring | Level 1                          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis                          
Fair value of marketable securities             $ 28,400,000       $ 28,400,000 24,800,000  
Mevo                          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis                          
Future potential earn-out payments   $ 17,000,000                      
Fair value of contingent consideration (earn-out)   $ 3,400,000                   $ 3,400,000  
Small Technology Acquisition                          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis                          
Future potential earn-out payments $ 10,000,000   $ 3,000,000                    
Number of technical development milestones | milestone 3   2                    
Streamlabs                          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis                          
Future potential earn-out payments       $ 29,000,000   $ 29,000,000              
Fair value of contingent consideration (earn-out)           $ 37,000             $ 23,300,000
Change in fair value of contingent consideration                   $ 5,700,000      
Marlin                          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis                          
Percent of voting interest acquired         8.90%                
Marlin | Notes Payable, Other Payables                          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis                          
Interest rate (as a percent)         6.00%                
Debt instrument, term         5 years